HYBRID EVENT: Join us in person in Rome, Italy or attend virtually from anywhere.

5th Edition of International Heart Congress

June 24-26, 2027 | Hybrid Event

June 24 -26, 2027 | Rome, Italy

Cardiac Tumor

Cardiac Tumor

Cardiac tumors are a rare but potentially serious medical condition characterized by the abnormal growth of cells within the heart. These tumors can be either benign or malignant, and they may originate within the heart itself (primary tumors) or spread to the heart from other parts of the body (secondary tumors). The symptoms of cardiac tumors can vary widely, ranging from chest pain and shortness of breath to irregular heartbeats and fatigue. Diagnosing cardiac tumors often involves a combination of imaging studies, such as echocardiography and cardiac MRI, along with biopsy procedures. Treatment options depend on the type, size, and location of the tumor, and may include surgery, chemotherapy, or radiation therapy. Due to the rarity of cardiac tumors, comprehensive research is ongoing to better understand their causes, risk factors, and optimal treatment strategies. Early detection and intervention are crucial for improving outcomes and minimizing the potential impact on cardiac function.

Committee Members
Speaker at International Heart Congress 2027 - Federico Benetti

Federico Benetti

Benetti Foundation, Argentina
Speaker at International Heart Congress 2027 - Mekhman N Mamedov

Mekhman N Mamedov

National Research Center for Preventive Medicine, Russian Federation
Speaker at International Heart Congress 2027 - Syed Raza

Syed Raza

Awali Hospital, Bahrain
Heart Congress 2027 Speakers
Speaker at International Heart Congress 2027 - Federico Benetti

Federico Benetti

Benetti Foundation, Argentina
Speaker at International Heart Congress 2027 - Mekhman N Mamedov

Mekhman N Mamedov

National Research Center for Preventive Medicine, Russian Federation
Speaker at International Heart Congress 2027 - Syed Raza

Syed Raza

Awali Hospital, Bahrain
Speaker at International Heart Congress 2027 - Uwe Peter Tigor

Uwe Peter Tigor

Auxilius Pharma, United States

Submit your abstract Today

Watsapp